Selenium Sulfide

Quick links to important sections

Selenium Sulfide

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Selenium Sulfide

Quick Facts: Selenium Sulfide

Property Description
Active ingredient Selenium Sulfide (Selenium disulfide, SeS2)
Form Aqueous Suspension (Lotion or Shampoo)
Pharmacological class Antiseborrheic and Antifungal Agent
Route of administration Topical
Origin Synthetic inorganic compound

What is Selenium Sulfide and Its Pharmacological Class?

Selenium Sulfide is a synthetic, inorganic chemical compound utilized as a topical medication for various skin and scalp conditions characterized by scaling and flaking. The chemical substance is officially known as selenium disulfide (SeS2), and its primary classification is an antiseborrheic and antifungal agent. This dual classification reflects its ability to manage conditions stemming from both excessive cellular turnover and the presence of certain surface fungi. The compound is used for its efficacy against Malassezia species, fungi often implicated in these conditions; this plays a role in controlling a key biological factor contributing to flaking. The compound has been available for dermatological use since the 1950s, highlighting its long-established presence in treatment protocols.

Composition and Topical Dosage Form

This medication is typically formulated as a single-ingredient product, with selenium disulfide being the sole active pharmaceutical ingredient. It is administered via the topical route directly to the affected skin or scalp. The common pharmaceutical preparation is an aqueous suspension, which means the active ingredient is finely dispersed in a liquid base, commonly presented as a lotion or shampoo. This topical application is designed to ensure the agent acts locally on the epidermis. The composition and form are optimized to deliver the compound to the target area without systemic effects. Selenium Sulfide is widely available both by prescription (Rx) and over-the-counter (OTC) in varying strengths, offering a flexible treatment option for patients.

General Purpose and Mechanism Summary

The general therapeutic purpose of Selenium Sulfide is to normalize the turnover cycle of the skin's epidermis, thereby managing symptoms related to excessive skin flaking and irritation. This is achieved through a combination of actions: it has an established antiproliferative (cytostatic) effect that actively slows the rapid growth and shedding of epithelial cells, and it demonstrates fungicidal activity. This dual mechanism—reducing cell overgrowth and managing microbial contribution—provides a targeted approach to sustained relief.

What side effects are possible with Selenium Sulfide?

Possible Side Effects and Safety Information

The official safety profile for topical Selenium Sulfide is structured around adverse reactions that are primarily local, explicit frequency classifications, and defined safety constraints, all sourced exclusively from government regulatory documents.


Adverse Reaction Scope

The adverse reactions associated with this topical agent are mainly confined to the site of application, categorized primarily under Skin and Subcutaneous Tissue Disorders.

Category Factual Regulatory Data
Frequency Classification Adverse reactions are classified with terminology such as More Common (e.g., unusual dryness or oiliness of the hair/scalp) and Less Common (e.g., increase in normal hair loss, localized skin irritation, burning, or stinging).
Common Reactions Changes in hair color (discoloration), particularly with lighter hair, and altered hair texture.
Serious Adverse Reactions Potential for generalized hypersensitivity reactions (allergic responses), which are considered serious adverse events documented in official labeling.

Regulatory Safety Considerations

The product label outlines specific constraints and warnings regarding use, particularly for patients with compromised skin integrity or those in certain populations.

  • Safety Restrictions: Use is contraindicated in cases of known or suspected hypersensitivity to any component. There is an explicit warning against applying the product to broken, raw, or inflamed skin due to the increased risk of systemic absorption and potential toxicity.
  • Population-Specific Safety: The product carries a Pregnancy Category C classification, meaning risk cannot be ruled out. Safety and effectiveness have not been established for use in infants and young children (under 2 or 5 years, depending on strength).

Connection to the overall safety profile: The official safety documentation confirms that the drug’s risk profile is dominated by localized skin and scalp effects whose occurrence is formally classified. The primary non-local safety consideration involves the documented risk of systemic toxicity if used on compromised skin.

Overdose and Emergency Response

The official regulatory profile for topical Selenium Sulfide overdose is strictly focused on the risks associated with accidental oral ingestion of the shampoo or lotion formulation. Swallowing the medication is classified by regulatory authorities as a scenario warranting immediate action due to the potential for systemic toxicity.

Should accidental ingestion occur, government labeling mandates that individuals seek emergency medical attention immediately by calling emergency services or contacting a Poison Control center. Overdose due to systemic exposure is officially linked to several clinical manifestations. Documented signs of toxicity include a distinct garlic odor of the breath, metallic taste, nausea, vomiting, lethargy, tremor, and abdominal pain.

In cases of high or repeated systemic exposure, regulatory documents cite the potential for severe outcomes, specifically damage to the liver and kidneys. No specific antidote for this form of toxicity is documented in official prescribing information, and the management approach is described as symptomatic and supportive treatment, with consideration given to the evacuation of stomach contents.

The risk of unwanted systemic absorption is also officially recognized when the product is applied topically to broken, inflamed, or oozing skin, a factor that increases the possibility of toxicity.

Therapeutic Uses of Selenium Sulfide

This topical agent is commonly used to treat conditions involving symptoms related to inflammatory or irritative states of the scalp and skin. The medication is utilized to help with symptoms related to physical discomfort, such as excessive scaling and flaking, which are characteristic of conditions like dandruff, Seborrheic Dermatitis, and Pityriasis Versicolor. It is applied in situations where symptoms create noticeable functional strain.

This supportive therapy plays a role in managing the symptom cluster of pruritus (itching) and localized cutaneous irritation that frequently occurs with scaling disorders. The therapeutic benefit supports the patient during difficult episodes by easing distress and contributes to improved comfort during periods of heightened symptoms.

This supportive therapy is relevant when supportive symptom management is appropriate for visible skin manifestations.

The agent is relevant in clinical settings marked by superficial fungal symptoms. For instance, the application may assist with symptoms related to fungal manifestations, which supports general well-being during symptomatic phases.


Quick Fact: Relief for Itching and Flaking

Symptom Domain Therapeutic Context Patient Benefit
Excessive Scaling Conditions characterized by periods of heightened symptoms Supports the patient during difficult episodes by easing distress
Pruritus (Itching) Symptoms related to inflammatory or irritative states Contributes to easing the overall symptom load
Discolored Patches Used in situations involving certain distressing symptoms Supports general well-being during symptomatic phases

Regulatory References

  1. NIH MedlinePlus overview of Selenium Sulfide

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Selenium Sulfide

This section outlines the official eligibility and non-eligibility information for Selenium Sulfide, based on regulatory labeling.

Population Category Eligibility Status (Regulatory Basis)
Hypersensitivity Contraindicated (Known or suspected allergy to selenium sulfide or any product ingredient)
Broken or Inflamed Skin Restriction (Do NOT use on broken skin, open wounds, or acutely inflamed areas due to risk of increased absorption)
Pediatric (Under 12 years) Use Not Established (Safety and effectiveness have not been established in children under 12 years of age for some formulations)
Pregnancy Not Recommended (US FDA labeling advises against use by pregnant women under ordinary circumstances; classified as Category C)
Lactation (Breastfeeding) Caution Exercised (Unknown if secreted in human milk; caution is advised when administering to a nursing woman)

Selenium sulfide is strictly for external use only. Non-eligibility is primarily defined by contraindication due to allergy and strong restrictions against application to compromised skin to prevent systemic exposure. Use in pediatric and pregnant populations requires specific consideration as defined in official labeling.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for topical Selenium Sulfide indicates that systemic drug-drug interactions are not documented due to the product’s limited absorption through intact skin. The interaction profile focuses on constraints related to the application area and substance contact, as defined in government-approved labeling.


Interaction Scope

Category Official Regulatory Status
Interacting Medicines None documented with other systemic or topical products.
Metabolic Interactions No clinically relevant CYP-mediated interactions are documented.
Food, Alcohol, Supplements No known interactions are specified in regulatory information.

Interaction Constraints and Conditions

Constraint Type Official Regulatory Statement
Exposure Modification Application to broken skin or skin with acute inflammation may lead to increased systemic absorption.
Timing Restriction Metallic objects or jewelry must be removed during use to prevent discoloration or damage by the product.
Population Note The use of the product is restricted on skin areas with compromised integrity due to increased absorption risk.

The regulatory profile reflects a low-complexity interaction structure defined by the topical route of administration. The primary documented constraint is pharmacokinetic, linking the potential for increased systemic exposure directly to the condition of the skin at the time of application, rather than to co-administered medicines.

Mechanism of Action

Selenium sulfide selectively accumulates in epidermal and follicular epithelial cells, where its mechanism of action is mediated through multiple intracellular pathways.

The primary biological target involves the inhibition of the enzyme succinate dehydrogenase within the cell's mitochondria. This interaction type is a non-competitive inhibitor of the enzyme, disrupting the proper functioning of the tricarboxylic acid (TCA) cycle and consequently impairing cellular respiration and ATP production.

This molecular perturbation leads to a reduction in the turnover rate and proliferation of the targeted epithelial cells. Furthermore, selenium sulfide interacts with keratinocyte processes, specifically decreasing their mitotic activity.

Downstream consequences include a diminished rate of epithelial cell shedding and turnover. At the system level, this physiological consequence is characterized by a modulatory effect on keratinization and the normalized rate of epithelial tissue desquamation.

Dosage and Administration Information

Selenium sulfide is administered exclusively via the topical route as an aqueous suspension, typically formulated as a lotion or shampoo, in available strengths such as 2.5%. As a standard requirement, the container must be shaken well immediately before application to ensure the active ingredient is uniformly dispersed.

The administration protocol is structured based on the intended site of application. For use on the scalp, the regimen for initial control involves applying approximately 5 to 10 mL (or 1-2 teaspoonfuls) to the wet scalp twice weekly for a period of two weeks. The suspension must be allowed to remain in contact with the scalp for a precise duration of 2 to 3 minutes before a thorough rinse.

Following the initial two-week control phase, the usage frequency is reduced to an intermittent maintenance pattern, such as every one, two, three, or four weeks, as necessary to maintain control. For application to the skin, a distinct regimen is followed, requiring application to the affected areas once daily for a full course of seven days. The specified contact time for skin application is longer, requiring the product to remain on the area for 10 minutes before a complete rinse.

Specific procedural constraints apply to use. Jewelry must be removed before use as the product can cause damage, and a thorough rinse is required after all applications, particularly for light or chemically treated hair, to minimize the potential for discoloration. Furthermore, the safety and effectiveness of certain strengths have not been established for use in infants or children under 12 years of age.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Selenium Sulfide

This overview summarizes the structure of the clinical research for Selenium Sulfide, detailing the conditions studied, the outcomes measured, and the recognized limits of the available evidence. This summary avoids clinical advice and does not describe how the medicine works or how it should be used.


Evidence for Use in Dandruff and Seborrheic Dermatitis of the Scalp

The available research exploring the use of Selenium Sulfide for scalp scaling conditions, which are often characterized by fluctuating or episodic symptoms, includes Randomized Controlled Trials (RCTs) and systematic reviews. The research was studied for adult and adolescent populations diagnosed with dandruff or the related condition, seborrheic dermatitis.

Researchers examined several outcomes, including the measurement of scaling and flaking scores, observations of scalp redness, and patient-reported outcomes describing perceived discomfort, like itching. Short-term trials findings describe patterns observed in the studied populations over periods, typically lasting up to four weeks. While evidence contributes to understanding symptom patterns over the short term, the evidence quality varies across studies.


Evidence for Use in Pityriasis Versicolor

Research for this specific fungal condition is largely based on double-blind Randomized Controlled Trials (RCTs). These studies was evaluated in adult and older adolescent patients. The trials research examined two main types of outcomes: mycological cure (fungal clearance) and the tracking of visible resolution of skin lesions. Follow-up research data show patterns related to symptom return in the intermediate term after treatment cessation.

A key challenge highlighted by the research is that the condition was associated with high rates of symptom return after discontinuation, a pattern observed across different study arms. Long-term effects are not fully established.


Research on Adjunctive Use in Tinea Capitis

Research for this use is strictly limited to its function as a supplementary (adjunctive) therapy alongside standard oral antifungal medication. The research available primarily examined children (typically aged 1–11 years old). The evidence is focused solely on this combination approach. Consequently, data for long-term outcomes regarding its use remains insufficient, and results apply only to the populations studied—children receiving concurrent oral therapy.

Key Studies & References

  1. Label: SELENIUM SULFIDE lotion (NIH DailyMed)
  2. Selenium Sulfide: MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Selenium Sulfide (FAQ)


Q: Is Selenium Sulfide used for anything besides dandruff?

Official regulatory documents indicate that in addition to common dandruff, Selenium Sulfide is also used to manage conditions such as seborrheic dermatitis. Furthermore, it is officially indicated for the management of tinea versicolor, which is a fungal infection of the skin.


Q: Why do official documents sometimes mention tinea versicolor for Selenium Sulfide?

Official product information mentions tinea versicolor because Selenium Sulfide is classified as having both antiseborrheic and antifungal properties. The antifungal classification means the product has been studied for its effects against the specific type of fungi associated with tinea versicolor.


Q: Can Selenium Sulfide change hair color?

Regulatory safety documents list hair discoloration and changes in hair color as potential side effects. This reaction is noted particularly with lighter hair colors or hair that has been chemically treated. Official guidance recommends thorough rinsing after application to help minimize the potential for this discoloration.


Q: Is it normal to feel a burning sensation when applying Selenium Sulfide?

Regulatory information lists localized skin irritation, burning, and stinging as potential, though less common, adverse reactions. Official labeling indicates that if sensitivity reactions are severe or worsen, discontinuation of the product is advised.


Q: Can using Selenium Sulfide cause hair thinning or loss?

The official regulatory safety profile includes an increase in normal hair loss as a documented potential adverse reaction. This is one of the less common effects listed in official labeling.


Q: What are the official guidelines about rinsing time after using Selenium Sulfide?

Official administration guidelines mandate a thorough rinse after the product's required contact time is complete. The required contact time varies: for use on the scalp, the product is typically left on for 2 to 3 minutes before rinsing; for application to other skin areas, the required contact time is 10 minutes.


Q: Why is the drug sometimes referred to as a 'cytostatic agent'?

Selenium Sulfide is described in official product information as having an antiproliferative, or 'cytostatic,' effect. This terminology reflects that part of its mechanism is to slow down the growth and turnover rate of the skin cells in the outer layer of the scalp and skin.


Q: Are there any specific cleaning instructions for my hands after using Selenium Sulfide?

Yes, to prevent potential transfer of the product, official instructions specify that users must wash their hands thoroughly after every application. It is also advised to clean under the nails to ensure all residual product is removed.


Q: What is the difference between Selenium Sulfide and zinc pyrithione?

Both Selenium Sulfide and zinc pyrithione are regulated and classified as agents used for managing dandruff and scaling. Official regulatory information shows that both are recognized for their antifungal properties. They are different chemical compounds, and sometimes zinc pyrithione may be listed as an inactive ingredient in a product where Selenium Sulfide is the primary active ingredient.


Q: Is the smell of Selenium Sulfide normal?

The product's odor is not directly addressed in patient labeling. However, due to the chemical nature of the compound, the product is known to possess a distinct odor. While the odor is not directly addressed in patient labeling, the chemical nature of the compound is known to possess a distinct odor.


Q: Can using too much Selenium Sulfide make the scalp condition worse?

Official guidance advises that the product should not be applied more frequently than the regimen specifies. Using the product more often than directed can lead to reported side effects such as localized scalp irritation, excessive oiliness, or unusual dryness.


Q: Does alcohol interact with the use of topical Selenium Sulfide?

According to official regulatory prescribing information, there are no known or documented interactions between topical Selenium Sulfide and the consumption of alcohol.


Q: Why do some people report an increased oily feeling after using it?

Official regulatory safety labeling lists unusual oiliness of the hair or scalp as one of the more common adverse reactions associated with the product. This effect is documented in the safety profile of the medication.


Q: Does the effectiveness of the medicine depend on the brand or concentration?

The medication is regulated and sold in specific strengths, such as 1% or 2.5%, and the strength is correlated with its stated uses and effectiveness as determined by official product labels. The official product label for any formulation must support its claimed benefits and uses.


Q: What is the function of the sulfur part of the name in the medicine?

The active compound is chemically known as Selenium disulfide (S eS2), meaning the sulfur component is chemically bonded to the selenium. This combined compound is the active ingredient responsible for the product's classification as an antiseborrheic and antifungal agent.


Q: Why is it advised to avoid using this product right before a perm or coloring?

Official guidance advises users to rinse the product thoroughly, especially when using it on color-treated or permed hair. This precaution is in place to minimize or prevent potential discoloration of the hair that can occur when the product is left in contact with chemically altered hair.


Q: Is it described as safe to use on facial skin?

Official warnings focus on avoiding the product near the eyes and strictly restrict its use on skin areas that are broken, raw, or acutely inflamed. While the medication is approved for use on the scalp and other affected skin areas, official labeling requires patients to adhere to avoiding areas of compromised skin integrity.


Q: What are the ingredients listed alongside Selenium Sulfide in commercial products?

Official prescribing information and drug facts labels (e.g., DailyMed) list the active ingredient, Selenium Sulfide, as well as various inactive ingredients. These commonly include water, stabilizing agents, fragrances, and preservatives, which differ based on the specific product formulation.


Q: Are there any specific age limit for using this medicine?

Official regulatory documents indicate that the safety and effectiveness of the medication have not been established in children under 12 years of age for certain formulations. Furthermore, it has not been established for children under 2 years of age for other uses, highlighting the need for specific consideration in pediatric populations.


Q: What are the differences between a Selenium Sulfide lotion and a shampoo?

Regulatory documents describe both lotion and shampoo as topical dosage forms of the medication. The key difference lies in the application protocol, where the two forms may have different designated contact times and instructions for use, depending on whether the medication is being applied to the scalp or another affected body area.


Q: Does Selenium Sulfide affect dye or chemically treated hair?

The official safety profile notes that the product may cause discoloration or change the color of chemically treated or dyed hair. To help prevent this, official regulatory labeling requires users to rinse the hair thoroughly immediately following use.


Q: How long does the effect of one treatment with Selenium Sulfide typically last?

Official guidance for maintenance use indicates that the medicine may be required at intervals ranging from every week up to every four weeks to maintain control. This suggests that the required frequency of application and duration of effect varies between individuals.

How should Selenium Sulfide be stored and disposed of?

How to Store and Dispose of Selenium Sulfide

The storage of selenium sulfide products is strictly defined by regulatory guidelines to ensure stability and safety.

Storage Conditions

Selenium sulfide must be stored at controlled room temperature between 20°C and 25°C (68°F and 77°F). It is mandatory to protect the product from freezing as this can compromise the suspension. The medication must be kept in the original container, which should be kept tightly closed, and stored out of the reach of children.

Disposal Instructions

Unused or expired selenium sulfide must be disposed of according to local regulations. It is officially recommended to not pour the product down a sink or flush it down a toilet unless explicitly instructed by official disposal programs. Drug take-back programs are the preferred method for discarding the medication.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Selenium Sulfide found in:

A-Z Index: